Data Driven Site Selection for Clinical Trials in a Post-COVID-19 World
September 20, 2021
4 Effective Strategies to Accelerate Site Selection to Activation
September 14, 2021
Aggregate Reporting – Significance, Classification and Challenges
September 2, 2021
Literature Screening – Process overview, challenges en-route and the scope for automation
August 30, 2021
How Decentralized Clinical Trials Are Expected to Transform the Conduct of Global Clinical Studies
August 5, 2021
How the Trial Master File is Expected to Evolve in the Next Three Years
July 28, 2021
Emerging Trends in Regulatory Affairs by Adapting to Latest Technological Advancements
July 5, 2021
Automation Opportunities in Pharmacovigilance
June 25, 2021
Global Regulatory Changes in Biopharma
June 21, 2021
Princeton Office
- 101 College Road East Princeton NJ 08540 USA
- SBH Officers Colony, Mega Hills, Ayyappa Society, Madhapur
- (040) 4503 8660
- CLINICAL
- REGULATORY
- Regulatory Capabilities Overview
- Regulatory Affairs Services
- Regulatory Operations Services
- eCTD Publishing & Submission
- Regulatory Dossier Gap Analysis (IND,NDA,BLA,ANDA,CTA,MAA, DMF)
- Post-Approval Gap Analysis
- Product Registrations
- Artwork & Labeling
- SPL Conversions
- RLD updates & Labeling Services
- QRD Preparation-EMA
- SmPC & ePI
- Local Labeling & Translations
- Labeling Compliance & Advisory
- REMS & RMP Plans
- Life Cycle Management Services
- Specialized & Niche Services
- Content Authoring Services
- PHARMACOVIGILANCE
- PV Capabilities Overview
- PV Technology Solutions
- PV Oversight & Agentic AI
- PV Functional Services
- TOTALVigilance Services
- Case Processing Services
- Aggregate Safety Reports
- Literature Monitoring Services
- Safety Signal Management
- QPPV & LPPV Services
- PSMF Lifecycle Management
- PV Risk Management Services
- Med Info Contact Center
- Materiovigilance Services
- PV Audits & Training Services
- PV Regulatory Intelligence Services
- QUALITY & LABS
- MEDTECH
- CAPABILITIES
- ABOUT